{
    "nct_id": "NCT03514069",
    "official_title": "Phase I Study of Ruxolitinib With Radiation and Temozolomide in Patients With Newly Diagnosed Grade III Gliomas and Glioblastoma",
    "inclusion_criteria": "Arm 1:\n\n* Patients must have unmethylated MGMT supratentorial high-grade glioma (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic mixed astro oligodendroglioma or glioblastoma).\n\nArm 2:\n\n* Patients must have supratentorial methylated MGMT high-grade glioma (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic mixed astro oligodendroglioma or glioblastoma).\n\nBoth:\n\n* Patients must have MRI or CT with contrast within 28 days prior to starting treatment.\n* Patients must have a Karnofsky performance status â‰¥ 70% (i.e. the patient must be able to care for himself/herself with occasional help from others).\n* Patients must have adequate blood, kidney and liver function\n* Patients must be able to provide written informed consent.\n* Patients and their sexual partners must agree to avoid conception while on the study due to possible risks from experimental drugs. Women will need a negative pregnancy test to be on the study\n* Patients may not have any other cancers except skin cancer and localized bladder, prostate, cervical, or breast cancer which were cured more than 3 years ago\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with other serious diseases\n* Pregnant women\n* Patients getting other cancer treatments\n* Patients with other cancers except for localized skin cancer and localized bladder, prostate, cervical, or breast cancer which were cured more than 3 years ago\n* Patients who have had repeat craniotomy for tumor therapy after receiving radiation therapy and temozolomide treatment.\n* Patients who have previously received other treatments for their cancers\n* Patient has previously taken ruxolitinib or is allergic to components of the study drug\n* Use of blood thinners\n* Human immunodeficiency virus (HIV) infection\n* Active hepatitis B or C infection\n* Heart diseases including abnormal electrocardiogram (EKG)\n* Patients unwilling or unable to follow this protocol",
    "miscellaneous_criteria": ""
}